Work

Targeting PI3K-β to develop novel combinational therapies for melanoma.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2620

Authors: Maegan Gabby, Zhi Sheng

Institution: Virginia Tech

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162553960

Cites:

Cited by:

Related to: